These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 12068915)

  • 1. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act.
    Cooper DE
    Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915
    [No Abstract]   [Full Text] [Related]  

  • 2. The 1941 sulfathiazole disaster and the birth of good manufacturing practices.
    Swann JP
    Pharm Hist; 1999; 41(1):16-25. PubMed ID: 11623769
    [No Abstract]   [Full Text] [Related]  

  • 3. The Federal Food and Drug Administration in the United States: born and bred in crises.
    Taylor WJ
    Int J Clin Pharmacol; 1973 Apr; 7(2):156-62. PubMed ID: 4581340
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioequivalence: the regulatory career of a pharmaceutical concept.
    Carpenter D; Tobbell DA
    Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Governmental oversight of prescribing medications: history of the US Food and Drug Administration and prescriptive authority.
    Plank LS
    J Midwifery Womens Health; 2011; 56(3):198-204. PubMed ID: 21535368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics, big business, and consumers. The context of government investigations into the postwar American drug industry.
    Bud R
    Technol Cult; 2005 Apr; 46(2):329-49. PubMed ID: 16116706
    [No Abstract]   [Full Text] [Related]  

  • 7. The Atlanta Falcon and Tono-Bungay: dietary supplements as subprime drugs.
    Weissmann G
    FASEB J; 2009 May; 23(5):1279-82. PubMed ID: 19406845
    [No Abstract]   [Full Text] [Related]  

  • 8. The FDA's regulation and control of antibiotics in the 1950s: the Henry Welch scandal, Félix Martí-Ibáñez, and Charles Pfizer & Co.
    McFadyen RE
    Bull Hist Med; 1979; 53(2):159-69. PubMed ID: 389316
    [No Abstract]   [Full Text] [Related]  

  • 9. The goose that laid the golden capsule, part I.
    Smith BE
    Tenn Med; 2005 May; 98(5):224-5. PubMed ID: 15934531
    [No Abstract]   [Full Text] [Related]  

  • 10. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

  • 11. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Johnny's in the basement, mixin' up the medicine. Review of Angell, Avorn, and Daemmrich on the modern pharmaceutical predicament.
    Mirowski P
    Soc Stud Sci; 2007 Apr; 37(2):311-27. PubMed ID: 17645149
    [No Abstract]   [Full Text] [Related]  

  • 13. Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration.
    Oram M
    Hist Psychiatry; 2016 Sep; 27(3):290-306. PubMed ID: 27194113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-to-consumer prescription drug advertising: history, regulation, and issues.
    Huh J; DeLorme DE; Reid LN; An S
    Minn Med; 2010 Mar; 93(3):50-2. PubMed ID: 20429178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
    Tobbell DA
    Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two centuries of assessing drug risks.
    Avorn J
    N Engl J Med; 2012 Jul; 367(3):193-7. PubMed ID: 22808954
    [No Abstract]   [Full Text] [Related]  

  • 17. Tobacco, public health, and the FDA.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2009 Jul; 361(4):402-3. PubMed ID: 19546344
    [No Abstract]   [Full Text] [Related]  

  • 18. Forbidden and Permitted Statements about Medications--Loosening the Rules.
    Avorn J; Sarpatwari A; Kesselheim AS
    N Engl J Med; 2015 Sep; 373(10):967-73. PubMed ID: 26332553
    [No Abstract]   [Full Text] [Related]  

  • 19. [The doctor's responsibility and risk in the prescribing of drugs].
    Aschenbrenner R
    Munch Med Wochenschr; 1973 Apr; 115(17):741-6. PubMed ID: 4574431
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence used for approval of new drugs.
    Botstein P
    Isr J Med Sci; 1986; 22(3-4):197-200. PubMed ID: 3528042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.